Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998050545) HUMAN SMT-3 LIKE PROTEIN
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/050545 International Application No.: PCT/US1998/008420
Publication Date: 12.11.1998 International Filing Date: 06.05.1998
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
Applicants:
INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive Palo Alto, CA 94304, US (AllExceptUS)
HILLMAN, Jennifer, L. [US/US]; US (UsOnly)
SHAH, Purvi [IN/US]; US (UsOnly)
Inventors:
HILLMAN, Jennifer, L.; US
SHAH, Purvi; US
Agent:
BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304, US
Priority Data:
08/853,97409.05.1997US
Title (EN) HUMAN SMT-3 LIKE PROTEIN
(FR) PROTEINE HUMAINE DE TYPE SMT-3
Abstract:
(EN) The present invention provides a human SMT3-like protein (HSMTH) and polynucleotides which identify and encoded HSMTH. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing HSMTH and for treating or preventing disorders associated with expression of HSMTH.
(FR) La présente invention concerne une protéine humaine de type SMT-3 (HSMTH) et des polynucléotides qui identifient et codent la HSMTH. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des agonistes, des anticorps et des antagonistes. En outre, l'invention se rapporte à des procédés de production de la HSMTH et à des procédés de traitement ou de prévention des troubles associés à l'expression de la HSMTH.
Designated States: AT, AU, BR, CA, CH, CN, DE, DK, ES, FI, GB, IL, JP, KR, MX, NO, NZ, RU, SE, SG, US
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU1998072598